AnGes, Inc.

JP EN

Harnessing gene power to make
treatment accessible to all
About AnGes

News

All

Development

Product Info

IR

Information

2026.02.24IR: Notice Regarding Execution of an Unsecured Private Placement Bond Facility (Revolving Type) Total Amount Purchase Agreement and Issuance of the 2nd Unsecured Corporate Bonds (Private Placement)

2026.02.24IR: Notice Regarding Partial Changes to the Use of Proceeds from the Issuance of the 46th Stock Acquisition Rights

2026.02.16IR: Introduction of the Policy Regarding Actions to Address Large-Scale Purchases of the Company’s Shares, etc. (Takeover Response Policy)

2026.02.10IR: Consolidated Financial Report for the Fiscal Year 2025

2026.01.06Development: Notice Regarding the Type “B” Clinical Meeting for HGF Gene Therapy Product

Learn more

Pipeline

Learn more

Global Alliance

Learn more

Contact us